Dr Peter Savas
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
84 Scholarly works
1 Projects
HIGHLIGHTS
2025
Journal article
Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines
DOI: 10.1038/s42003-025-08251-02025
Journal article
Baseline tumour burden and prognosis in breast cancer treated with immune checkpoint inhibitors
DOI: 10.1016/j.breast.2025.1045862025
Journal article
Whole-genome sequencing in breast cancer: is it ready for clinical application?
DOI: 10.1016/S1470-2045(25)00428-02025
Journal article
Impact of exercise on sexual health, body image, and therapy-related symptoms in women with metastatic breast cancer: The randomized controlled PREFERABLE-EFFECT trial
DOI: 10.1002/ijc.354292025
Journal article
Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer
DOI: 10.1158/1055-9965.EPI-24-15262023
Research grants (international)
Virtual Cancer Prevention Centre
2014
Journal article
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data
DOI: 10.1186/s13059-014-0470-7
RECENT SCHOLARLY WORKS
2025
Journal article
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers
DOI: 10.1111/cts.701442025
Journal article
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials
DOI: 10.1200/PO-24-005992024
Journal article
Sustained lymphocyte decreases after treatment for early breast cancer
DOI: 10.1038/s41523-024-00698-42024
Journal article
Annotation-efficient deep learning for breast cancer whole-slide image classification using tumour infiltrating lymphocytes and slide-level labels
DOI: 10.1038/s44172-024-00246-92024
Journal article
The anti-cancer immune response in breast cancer: current and emerging biomarkers and treatments
DOI: 10.1016/j.trecan.2024.02.008